ARCHIVES

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

This article is from The Cancer Letter archive.

Vol. 38 No. 31 | August 3, 2012

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Hatch Introduces Bill to Modify Delaney Amendment

June 13, 1986

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

May 11, 2012

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990